US Patent Issued to THE UNIVERSITY OF CHICAGO on July 7 for "Methods and compositions for treating cancer with cancer-targeted adjuvants" (Illinois Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,113, issued on July 7, was assigned to THE UNIVERSITY OF CHICAGO (Chicago).

"Methods and compositions for treating cancer with cancer-targeted adjuvants" was invented by Jeffrey A. Hubbell (Chicago), David S. Wilson (Chicago), Tiffany M. Marchell (Chicago) and Laura T. Gray (Chicago).

According to the abstract* released by the U.S. Patent & Trademark Office: "Here, the inventors describe methods and compositions for targeting a TLR agonist to the tumor cell or stroma. Aspects of the disclosure relate to a polypeptide comprising a tumor targeting agent operatively linked to p(Man-TLR). Also disclosed are compositions and methods for treating cancer in a subject comprising administr...